Literature DB >> 30864496

Current Concepts of the Pathogenesis of Aplastic Anemia.

Chunyan Liu1, Yingying Sun1, Zonghong Shao1.   

Abstract

Abnormal activation of the immune system plays an important role in the pathogenesis of aplastic anemia (AA). Various immune cells and cytokines constitute a complex immune network, leading to bone marrow failure. The known pathogenesis is an increase of the myeloid dendritic cell (mDC)/ plasmacytoid dendritic cell (pDC) ratio, which causes the ratio of T helper (Th)1/Th2 to be skewed in favor of Th1 and eventually leads to an abnormal activation of cytotoxic T lymphocyte (CTL). The antigens that stimulate T cells in the context of AA remain unknown. In this process, regulatory T (Treg), Th17, natural killer (NK) cell, memory T cell and negative hematopoietic regulatory factors are also involved. In addition, genetic background (e.g., chromosomal abnormalities, telomere attrition, somatic cell mutations), abnormal bone marrow hematopoietic microenvironment and viral infection may also contribute to the pathogenesis of AA. This review summarizes the recent studies of the pathogenesis of AA and the current status of AA research. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Aplastic Anemia; bone marrow failure ; cytokines; immunosuppressive therapies; myeloid dendritic cell; pathogenesis.

Mesh:

Year:  2019        PMID: 30864496     DOI: 10.2174/1381612825666190313113601

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

1.  Decreased LAG3 expression on T effector cells and regulatory T cells in SAA.

Authors:  Yingying Sun; Chunyan Liu; Ting Jiao; Ning Xie; Huaquan Wang; Weiwei Qi; Zonghong Shao
Journal:  Int J Hematol       Date:  2020-08-12       Impact factor: 2.490

2.  Cofilin-1 participates in the hyperfunction of myeloid dendritic cells in patients with severe aplastic anaemia.

Authors:  Yingying Sun; Yu Zhang; Hong Yu; Huaquan Wang; Zonghong Shao; Chunyan Liu
Journal:  J Cell Mol Med       Date:  2022-05-17       Impact factor: 5.295

3.  Identification of Differentially Expressed lncRNAs and mRNAs in Children with Acquired Aplastic Anemia by RNA Sequencing.

Authors:  Shuanglong Lu; Xiaoxiao Song; Jing Chen; Xiaohong Qiao
Journal:  Biomed Res Int       Date:  2020-06-28       Impact factor: 3.411

4.  Upregulated expression of leukocyte immunoglobulin-like receptor A3 in patients with severe aplastic anemia.

Authors:  Hong Yu; Hui Liu; Yang Zhao; Huaquan Wang; Chunyan Liu; Weiwei Qi; Zhaoyun Liu; Yingying Sun; Shan Gao; Jinglian Tao; Rong Fu; Zonghong Shao
Journal:  Exp Ther Med       Date:  2021-02-11       Impact factor: 2.447

5.  Myeloid dendritic cells in severe aplastic anemia patients exhibit stronger phagocytosis.

Authors:  Yingying Sun; Chengcheng Wu; Chunyan Liu; Huaquan Wang; Yang Zhang; Yu Zhang; Ningyuan Ran; Zonghong Shao
Journal:  J Clin Lab Anal       Date:  2021-10-18       Impact factor: 2.352

6.  Abnormal miR-214/A20 expression might play a role in T cell activation in patients with aplastic anemia.

Authors:  Zhi Yu; Cunte Chen; Yankai Xiao; Xiaohui Chen; Lixing Guo; Guangxiao Tan; Guixuan Huang; Weifeng Luo; Ming Zhou; Yumiao Li; Chen Lin; Qi Shen; Yuping Zhang; Bo Li
Journal:  Blood Sci       Date:  2020-07-25

7.  Abnormal Proteomics Profile of Plasma Reveals the Immunological Pathogenesis of Severe Aplastic Anemia.

Authors:  Weiwei Qi; Yu Zhang; Wenhao Yang; Chunyan Liu; Huaquan Wang; Rong Fu; Zonghong Shao
Journal:  Dis Markers       Date:  2022-05-06       Impact factor: 3.434

8.  Upregulated Expression of Profilin1 on Dendritic Cells in Patients With Severe Aplastic Anemia.

Authors:  Hong Yu; Yang Zhao; Xiaofeng Pan; Chunyan Liu; Rong Fu
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

9.  Single-Cell RNA-Seq of Bone Marrow Cells in Aplastic Anemia.

Authors:  Hu Tonglin; Zhao Yanna; Yu Xiaoling; Gao Ruilan; Yin Liming
Journal:  Front Genet       Date:  2022-01-03       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.